

According to industry sources on the 31st, Merck Life Sciences, a global life science company, has long been investing in Korea’s science and technology through awards, researchers and academic society support, and talent development programs.
Science and technology directly translate to national competitiveness.
This is why countries around the world make efforts to further their competitiveness in science and technology.
The US Biden administration emphasized that the development of science and technology will become a 'game changer' in the field of healthcare, and the medical and pharmaceutical industry will become indispensable for national security over the next 10 years.
The Korean government has also been prioritizing science and technology in all its policies.
At a recent meeting with senior secretaries, President Yoon stressed that growth can only be achieved through scientific and technological innovation, saying, "science and technology are important to ensure sustainable growth of the country." President Yoon also emphasized the importance of science and technology in the past, saying, "This is an era where science and technology are directly linked not only to the nation's future but our survival.” Merck Life Science has shown interest in strengthening Korea’s science and technology from early on.
It has been supporting the research of Korean scientists for over 20 years and striving to cultivate pharmaceutical and bio talent with leading universities in Korea.
This is a rare case where a global company has taken the initiative to invest in the development of science and technology in Korea.
◆Full support to foster talents that will lead the development of science and technology in the future

Through the program, Merck provided support for scholarships and mentoring, business development to establish a safe laboratory environment, to foster industry leaders and life-respecting pharmaceutical care experts.
The company also supported human and material resources necessary for the research and development of new bio drugs.
Since 2021, at Sungkyunkwan University’s Institute of Quantum Biophysics, the company has been collaborating with the school, cooperating in the research and development of diagnosis and disease treatments based on quantum biophysical theory and phenomena.
For this, the company has been providing seminars and training programs for knowledge and information exchange, as well as scholarship support and internship programs to procure talent in the life sciences sector.
Also, the company has provided opportunities for students to experience the industry and provided information on the pharmaceutical and bio industry.
Last year, Merck Life Science participated in the ‘SNU Bio-Day’ hosted by Seoul National University’s Bio-MAX Institute and introduced how the technology of the global company Merck is applied in the field to derive scientific results.
Also, the company hosted a field trip to Merck Life Science’s Custom Synthesis Lab as part of the Kiuri Project workshop program run by Seoul National University’s Bio-MAX Institute.
◆Has awarded outstanding scientists in Korea for 20 years...promoting active research Also, the company has been supporting the research activities of scientists in Korea in partnership with prestigious academic societies in Korea through awards.
The Sigma-Aldrich Chemist Award that Merck Life Science held with the Korean Chemical Society has celebrated its 20th year this year.
The award is given every year to 2 chemists with outstanding research achievements and outstanding creativity in the field of chemistry.
This traditional award has a long history and has been given even before the merger of Merck and Sigma Aldrich.
The award is presented every year at KCA’s regular autumn conference.

Every year, three first authors (research professors) and postdoctoral researchers that performed outstanding research achievements related to molecular cell biology are selected for the award.
The award ceremony is held at the Autumn Conference of the Korean Molecular Cell Biology Association, with lectures by the awardees.
For objectivity and transparency, candidates are nominated by regular members of KSMCB, and the awardee is selected through a strict review by the Academic Research Award Committee, without any involvement on Merck Life Science’s part.
◆Merck’s science journal issued a special feature on Korea...shed light on domestic science and technology research

Recently, in its global science journal ‘Material Matters,’ Merck issued a special feature on Korean scientists, introducing 4 renowned professors in Korea and their research Material Matters is a scientific journal prepared to provide information on material science and nanotechnology necessary for scientific research.
The journal reviews technologies and their applications by world scholars on a specific subject, and is distributed to research institutes around the world.
Korea’s special edition of Material Matters featured:▲Seoul National University Professor Yung-Eun Sung’s discussion on ‘PGM and PGM-free Catalysts for Polymer Electrolyte Membrane Fuel Cells’, ▲Korea Advanced Institute of Science and Technology (KAIST) Professor Byeong-Soo Bae’s review of Sol-Gel Derived Siloxane-Encapsulated Luminescent Nanocrystal Composites for Optoelectronics and Display,’ ▲ Yonsei University Professor Woo-Dong Jang’s research on ‘Poly (2-isopropyl-2-oxazoline)-based Multimodal Stimuli-responsive Functional Materials,’ and ▲Yonsei University Professor Wooyoung Shim’s research on ‘Phyllosilicate Clay Minerals: Principles and Applications’
댓글 운영방식은
댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.
댓글 노출방식은
댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.
댓글의 삭제 기준은
다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.
저작권·인격권 등 타인의 권리를 침해하는 경우
상용 프로그램의 등록과 게재, 배포를 안내하는 게시물
타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물
근거 없는 비방·명예를 훼손하는 게시물
특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우
특정 지역 및 종교간의 감정대립을 조장하는 내용
사실 확인이 안된 소문을 유포 시키는 경우
욕설과 비어, 속어를 담은 내용
정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)
특정 지역이나 단체를 비하하는 경우
특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우
특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우
타인의 ID 혹은 닉네임을 도용하는 경우
게시판 특성상 제한되는 내용
서비스 주제와 맞지 않는 내용의 글을 게재한 경우
동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우
부분적으로 변경하여 반복 게재하는 경우도 포함
제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우
돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물
게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우
수사기관 등의 공식적인 요청이 있는 경우
기타사항
각 서비스의 필요성에 따라 미리 공지한 경우
기타 법률에 저촉되는 정보 게재를 목적으로 할 경우
기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용
사실 관계 확인 후 삭제
저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우
타인의 초상권을 침해하거나 개인정보를 유출하는 경우
당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)
※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.
※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.
※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.